To assess efficacy and safety of oral treatment with prednisone at immunosuppressive dose after percutaneous coronary interventions (PCI) in patients with multi-vessel coronary artery disease (CAD).
Ribichini, F., Tomai, F., Ferrero, V., Versaci, F., Boccuzzi, G., Proietti, I., et al. (2005). Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease: the IMPRESS-2/MVD study. EUROINTERVENTION, 1(2), 173-180.
Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease: the IMPRESS-2/MVD study
Tomai, FabrizioMembro del Collaboration Group
;Versaci, FrancescoWriting – Review & Editing
;Proietti, IginoMembro del Collaboration Group
;
2005-08-01
Abstract
To assess efficacy and safety of oral treatment with prednisone at immunosuppressive dose after percutaneous coronary interventions (PCI) in patients with multi-vessel coronary artery disease (CAD).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Ribichini_EuroIntrv_2005.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
3.64 MB
Formato
Adobe PDF
|
3.64 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
